Management of the Regional Lymph Nodes in Early-Stage Breast Cancer
- 1 January 2016
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 26 (1) , 37-44
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Radiation Field Design in the ACOSOG Z0011 (Alliance) TrialJournal of Clinical Oncology, 2014
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialThe Lancet Oncology, 2014
- Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trialThe Lancet Oncology, 2013
- Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011Breast Cancer Research and Treatment, 2013
- Radiation field design and regional control in sentinel lymph node‐positive breast cancer patients with omission of axillary dissectionCancer, 2011
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Long-Term Follow-Up Confirms the Oncologic Safety of Sentinel Node Biopsy Without Axillary Dissection in Node-Negative Breast Cancer PatientsAnnals of Surgery, 2010
- Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)Acta Oncologica, 2010
- Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trialThe Lancet Oncology, 2007
- Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyThe Lancet Oncology, 2006